Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
about
In Vivo Noninvasive Imaging for Gene TherapyCytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cellsIncreased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 geneMolecular Targeted Therapies of Aggressive Thyroid CancerIntegrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.Ovarian teratoma mimicking metastasis on I-131 scan : a case report.Advances in preclinical investigation of prostate cancer gene therapy.Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapyRecurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.The sodium iodide symporter and thyroid disease.Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases.DNA methylation in thyroid tumorigenesis.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskMolecular imaging of gene therapy for cancer.Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.Propylthiouracil increases sodium/iodide symporter gene expression and iodide uptake in rat thyroid cells in the absence of TSH.Efficient multicistronic co-expression of hNIS and hTPO in prostate cancer cells for nonthyroidal tumor radioiodine therapy.Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts.Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience.Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.Thyroid-Specific Genes Expression Uncovered Age-Related Differences in Pediatric Thyroid Carcinomas.Clinical significance of discordant findings between pre-therapy (123)I and post-therapy (131)I whole body scan in patients with thyroid cancer.Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomographyRadioiodine-induced kidney damage and protective effect of amifostine: An experimental study.The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.The Na+/I- symporter (NIS): mechanism and medical impact.Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.A Novel Ideal Radionuclide Imaging System for Non-invasively Cell Monitoring built on Baculovirus Backbone by Introducing Sleeping Beauty Transposon.Quantitative reverse transcription polymerase chain reaction-based detection of thyroid-specific gene expression in fine-needle aspirate for thyroid cancer recurrence evaluation: a case report and review of the literature.Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer.Cholangiocarcinoma: from molecular biology to treatment.Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma.Radioiodine therapy of thyroid carcinoma following Pax-8 gene transfer.The effects of amitrole on thyroglobulin and iodide uptake in FRTL-5 cells.
P2860
Q24790997-4BAD6298-13B5-4F82-AA31-2237238469F3Q24793862-F861B8A8-BA0E-42F1-AC3B-FCDD48523AFBQ24794449-00CF4063-9798-490B-9526-6E3FE3C4756CQ24814886-78967084-F366-45BC-900E-76C2E3E3C47EQ26774734-B457BF62-B98E-483E-9290-65DCF549A3F3Q33629836-7103A524-C6CF-43E5-BDD7-22DF2823852CQ33670050-29E9C062-92E8-4B43-A1F8-B63189A64906Q33677054-2AD1E5FF-F81C-478C-9187-94D24B24D364Q33690729-72B7E20F-8CAA-447B-B425-B550003FDE82Q33759426-3F0A2827-BD13-4C2B-9527-6B1C0702B2A1Q34609548-CD1A4275-915A-496A-A56D-5943317C0CAAQ34646939-D8050F6C-ACFC-4AD1-944E-687BA93FDF91Q34698684-D09A4973-3A26-490E-9046-0C951C7155EDQ35007015-352F6D58-34CE-4A3B-9FC6-258358386797Q35086482-53B3C5F5-F544-42CB-A83A-1968EEBCEAF1Q35668946-6248C8BC-D861-41BC-AB55-2DC84A16F7F8Q35772207-69FEEDD7-1E09-4910-8ADC-794FE796E89EQ35826582-D92F0C25-5028-4023-A6F4-6409D4E60895Q36046238-CBE1E420-725C-4657-A85E-13EC4EC96BF0Q36124300-F1B3FB79-7E6B-4996-97FE-B32291BEC525Q36357754-078779F9-D307-4823-A9B9-146B1E2E0ED7Q36514677-8AB9666E-E572-4A6B-990F-8FABDABBDE6FQ36527774-42E7349C-871A-4B00-9CDE-A53DE84DFEBDQ36627336-DB0FF354-7E45-4E1D-BD7D-7466E29D99DEQ36679734-B79749EB-5103-4248-BCBC-7D40665B0328Q36875214-1D1F90A3-CDCC-48CF-AE2A-E5E8D5261A11Q36986737-134818B3-9C6A-4110-9C46-3222728D08CFQ37035249-919A766E-BCAD-4841-9C7C-9C72114BC31CQ37082662-17239705-45A2-4C17-935B-3DA8956FAA89Q37449178-A824621B-017E-4517-A729-54F25EB82C20Q37494004-B4089057-F14C-49A1-A054-BF20A6F852D4Q37587879-CAD3006A-E868-484F-82BA-A3438FFD9649Q37682206-AE5414A0-5946-4204-9D13-9FE0B200CC12Q38382326-FA554349-CA39-4798-998F-0BCB04672999Q38472945-8E4F8784-03AE-47CD-9015-A201F5C92E8FQ38597008-334DD108-6E83-4017-A81D-BF314559DCF6Q38675367-DBFE543C-D87D-47E5-9E0C-253979EA8873Q38690343-1E75808F-5DF1-472A-9149-BC9401551623Q39492007-B429BB9E-649E-4CFA-8894-A11346CBF415Q39645678-536478EB-B4B0-4604-8A08-D23CFE5537B2
P2860
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@ast
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@en
type
label
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@ast
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@en
prefLabel
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@ast
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@en
P2093
P356
P1476
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
@en
P2093
P304
P356
10.1530/EJE.0.1410443
P577
1999-11-01T00:00:00Z